טוען...

ACT-10 TREATMENT FOR GLIOBLASTOMA RECURRED AFTER CONCOMITANT CHEMORADIATION THERAPY WITH TEMOZOLOMIDE AND THEIR PROGNOSIS

There are few data about treatment for glioblastoma recurred after concomitant chemoradiation therapy with temozolomide (TMZ). We retrospectively examined treatment and prognosis of recurred glioblastoma patients who registered Kansai molecular diagnosis network for central nervous system tumors, an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neurooncol Adv
Main Authors: Mori, Kanji, Shofuda, Tomoko, Mano, Masayuki, Kodama, Yoshinori, Kinoshita, Manabu, Arita, Hideyuki, Moriuchi, Shusuke, Uda, Takehiro, Taki, Takuyu, Fukai, Junya, Nonaka, Masahiro, Ishibashi, Kenichi, Sakamoto, Daisuke, Izumoto, Shuichi, Nishida, Namiko, Okita, Yoshiko, Nakajima, Yoshikazu, Takano, Koji, Hashimoto, Naoya, Tsuyuguchi, Naohiro, Okuda, Takeshi, Achiha, Takamune, Hayashi, Nobuhide, Dehara, Makoto, Kanemura, Yonehiro
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.061
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!